Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glaudemans

Showing results (381-390 of 396) with videos related to

Pageof 40
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
Validation of a Deep-Learning Coregistration Framework for Long-Axial-Field-of-View PET/CT Using Low-Radiation-Exposure Protocols Across Various TracersZekai Li, Laura Providência, Philipp Mohr, et al.
Kidney International|July 15, 2019
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammationDaniela Egli-Spichtig, Pedro Henrique Imenez Silva, Bob Glaudemans, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2014
Common variants in UMOD associate with urinary uromodulin levels: a meta-analysisMatthias Olden, Tanguy Corre, Caroline Hayward, et al.
Molecular Cancer Therapeutics|April 12, 2023
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug ConjugatePatrick G Groothuis, Daniëlle C H Jacobs, Inge A T Hermens, et al.
Circulation|July 19, 2018
Improving the Diagnostic Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve EndocarditisLaurens E Swart, Anna Gomes, Asbjørn M Scholtens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2015
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate TreatmentLaetitia E Lamberts, Catharina W Menke-van der Houven van Oordt, Eva J ter Weele, et al.
EJNMMI Research|January 24, 2022
Validation and test-retest repeatability performance of parametric methods for [<sup>11</sup>C]UCB-J PETHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Journal of Cardiac Failure|September 2, 2019
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate UtilizationSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 31, 2019
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilizationSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
JAMA Oncology|April 16, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort TrialJasper J L van Geel, Bertha Eisses, Sjoerd G Elias, et al.
Pageof 40

Showing results (381-390 of 396) with videos related to

Sort By:
Pageof 40
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
Validation of a Deep-Learning Coregistration Framework for Long-Axial-Field-of-View PET/CT Using Low-Radiation-Exposure Protocols Across Various TracersZekai Li, Laura Providência, Philipp Mohr, et al.
Kidney International|July 15, 2019
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammationDaniela Egli-Spichtig, Pedro Henrique Imenez Silva, Bob Glaudemans, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2014
Common variants in UMOD associate with urinary uromodulin levels: a meta-analysisMatthias Olden, Tanguy Corre, Caroline Hayward, et al.
Molecular Cancer Therapeutics|April 12, 2023
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug ConjugatePatrick G Groothuis, Daniëlle C H Jacobs, Inge A T Hermens, et al.
Circulation|July 19, 2018
Improving the Diagnostic Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve EndocarditisLaurens E Swart, Anna Gomes, Asbjørn M Scholtens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2015
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate TreatmentLaetitia E Lamberts, Catharina W Menke-van der Houven van Oordt, Eva J ter Weele, et al.
EJNMMI Research|January 24, 2022
Validation and test-retest repeatability performance of parametric methods for [<sup>11</sup>C]UCB-J PETHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Journal of Cardiac Failure|September 2, 2019
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate UtilizationSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 31, 2019
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilizationSharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
JAMA Oncology|April 16, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort TrialJasper J L van Geel, Bertha Eisses, Sjoerd G Elias, et al.
Pageof 40